US Regulatory Reads, January 2019: Risk Management, 510(k) Reforms And The Shutdown
Executive Summary
The partial government shutdown left a major shadow on the medtech regulatory world for much of January, but there also were several other important substantive issues addressed by MTI last month that did not escape Medtech Insight readers' attention. A look at the top stories from the month.